Sponsored by the HealthcareTrainingInstitute.org providing Quality Education since 1979
Add to Shopping Cart

HIV: Effective Tools & Techniques for the Caregiver
6 CEUs Cultural Diversity & Ethical Boundaries: Freedom from Stereotypes

Section 18
State HIV Prevention Progress Report 2014

Answer Booklet | Table of Contents | HIV/AIDS CEU Courses
Psychologist CEs, Counselor CEUs, Social Worker CEUs, MFT CEUs


The Flip Book below is from Centers for Disease Control and Prevention 

Hint:
1. Use + and – at top of page to increase or decrease size
2. Click and drag on page to move text to be more visible , if needed
3. Click speaker at top of page to add or delete sound
4. If message below indicates "A plugin is needed to display this content." CLICK HERE
Questions? Email: [email protected]

- Dietz, Patricia M. ,DrPH, Amy L. Krueger, MPH, Richard J. Wolitski, PhD, Anna Satcher Johnson, MPH, Erica Dunbar, MPH, Lillian S. Lin, PhD, Samuel Dooley, MD, Donna Hubbard McCree, PhD, Shubha Rao, MPH, H. Irene Hall, PhD Dale Stratford, PhD, State HIV Prevention Progress Report 2014, Centers for Disease Control and Prevention 2014, p1-108.


 
Others who bought this HIV/AIDS Course
also bought…

Scroll DownScroll UpCourse Listing Bottom Cap

Answer Booklet for this course | HIV/AIDS
Forward to Section 19
Back to Section 17
Table of Contents
Top

The article above contains foundational information. Articles below contain optional updates.
Triple combination cures most hepatitis C patients with prior DAA treatment failure - April 28, 2017
Almost all people with genotype 1 hepatitis C who were previously unsuccessfully treated with a course of interferon-free direct-acting antiviral therapy achieved sustained response when retreated with a three-drug combination being developed by Merck, researchers reported at the International Liver Congress last week in Amsterdam. Direct-acting antivirals (DAAs) have revolutionised the treatment of chronic hepatitis C
Early ART highly acceptable and achieves excellent rates of viral suppression among young South African women - April 27, 2017
Early antiretroviral therapy (ART) is highly acceptable to the majority of young women with HIV in South Africa, according to research published in AIDS and Behavior. Rates of virological suppression remained at over 85% regardless of CD4 threshold for starting treatment, and answers to a questionnaire showed that over three-quarters of participants were
EASL releases updated hepatitis B guidelines at International Liver Congress - April 26, 2017
The European Association for the Study of the Liver (EASL) presented revised clinical practice guidelines for the management of hepatitis B virus (HBV) infection – the first update since 2012 – during a special session at its International Liver Congress last week in Amsterdam. For the first time the guidelines include tenofovir alafenamide and present
Switching to TAF for hepatitis B improves kidney function and bone loss - April 26, 2017
People with hepatitis B who switched from the old tenofovir disoproxil fumarate (TDF) to the new tenofovir alafenamide (TAF) saw improvements in kidney function biomarkers and recovery of bone loss, researchers reported at the International Liver Congress last week in Amsterdam. The congress is the annual meeting of the European Association for the Study of
A quarter of people taking antiretroviral therapy in Kenya have exhausted current treatment options - April 25, 2017
Affordable third-line antiretrovirals are urgently needed in resource-limited settings, according to research conducted in Kenya and published in the online edition of AIDS. The study showed that a quarter of patients had exhausted current treatment options and only 18% had virus that was fully susceptible to the three main classes of anti-HIV drugs. “This

CEU Continuing Education for
Social Work CEUs, Psychology CEUs, Counselor CEUs, MFT CEUs

 


OnlineCEUcredit.com Login


Forget your Password Reset it!